JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB287893

Anti-EZH2 antibody [EPR24902-112]

  • 20ul selling size
  • Recombinant
  • RabMAb
  • KO Validated
  • What is this?

Be the first to review this product! Submit a review

|

(0 Publication)

Knockout Tested Rabbit Recombinant Monoclonal KMT6 / EZH2 antibody. Suitable for WB, I-ELISA and reacts with Human, Mouse, Synthetic peptide samples.

View Alternative Names

KMT6, EZH2, Histone-lysine N-methyltransferase EZH2, ENX-1, Enhancer of zeste homolog 2, Lysine N-methyltransferase 6

4 Images
Western blot - Anti-EZH2 antibody [EPR24902-112] (AB287893)
  • WB

Supplier Data

Western blot - Anti-EZH2 antibody [EPR24902-112] (AB287893)

ab287893 was shown to specifically react with EZH2 (pT345) in untreated Wild-type HAP1, HeLa and NIH/3T3 (Figure A). After treatment with 150 units alkaline phosphatase for 1 hour at 37°C, no band was observed (Figure B). Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T). ab287893 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilutions, respectively. Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.​

All lanes:

Western blot - Anti-EZH2 antibody [EPR24902-112] (ab287893) at 1/1000 dilution

Lane 1:

Wild-type HAP1 cell lysate at 20 µg

Lane 2:

EZH2 knockout HAP1 cell lysate​ at 20 µg

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

NIH/3T3 cell lysate at 20 µg

Secondary

Lanes 1 - 4:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 4:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 98 kDa,37 kDa

false

Western blot - Anti-EZH2 antibody [EPR24902-112] (AB287893)
  • WB

Supplier Data

Western blot - Anti-EZH2 antibody [EPR24902-112] (AB287893)

ab287893 was shown to specifically react with EZH2 (pT345) in HEK-293. The signal was significantly reduced after blocking with 1µg/ml histone-lysine N-methyltransferase EZH2 peptide (pT345). Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T). ab287893 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilutions, respectively. Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.​

All lanes:

Western blot - Anti-EZH2 antibody [EPR24902-112] (ab287893) at 1/1000 dilution

Lane 1:

HEK-293 cell lysate at 20 µg

Lane 2:

HEK-293 cell lysate with histone-lysine N-methyltransferase EZH2 peptide (unmodified) at 1µg/ml​ at 20 µg

Lane 3:

HEK-293 cell lysate with histone-lysine N-methyltransferase EZH2 peptide (pT345) at 1µg/ml at 20 µg

Secondary

Lanes 1 - 3:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 3:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 98 kDa,37 kDa

false

Western blot - Anti-EZH2 antibody [EPR24902-112] (AB287893)
  • WB

Supplier Data

Western blot - Anti-EZH2 antibody [EPR24902-112] (AB287893)

ab287893 was shown to specifically react with EZH2 (pT345) in HeLa and NIH/3T3. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T). ab287893 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilutions, respectively. Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.​

All lanes:

Western blot - Anti-EZH2 antibody [EPR24902-112] (ab287893) at 1/1000 dilution

Lane 1:

HeLa cell lysate at 20 µg

Lane 2:

NIH/3T3 cell lysate​ at 20 µg

Secondary

Lanes 1 - 2:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 2:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 98 kDa,37 kDa

false

Indirect ELISA - Anti-EZH2 antibody [EPR24902-112] (AB287893)
  • I-ELISA

Supplier Data

Indirect ELISA - Anti-EZH2 antibody [EPR24902-112] (AB287893)

Indirect ELISA showing the phospho-specificity (pT345) of primary antibody ab287893. Plates were coated with histone-lysine N-methyltransferase EZH2 (pT345), histone-lysine N-methyltransferase EZH2 (pT345), histone-lysine N-methyltransferase EZH2 peptide (unmodified) and histone-lysine N-methyltransferase EZH2 peptide (pT487) peptides at 1000 ng/ml. Binding of ab286909 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution).​

Binding was detected using pre-adsorbed secondary antibody, goat anti-rabbit IgG H&L (HRP, ab97080) at 1/2000 dilution.​

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR24902-112

Isotype

IgG

Carrier free

No

Reacts with

Human, Mouse

Applications

I-ELISA, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IELISA" : {"fullname" : "Indirect ELISA", "shortname":"I-ELISA"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IELISA-species-checked": "guaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IELISA-species-checked": "guaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Synthetic peptide": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IELISA-species-checked": "testedAndGuaranteed", "IELISA-species-dilution-info": "1000 ng/mL", "IELISA-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Enhancer of Zeste Homolog 2 (EZH2) is an enzymatic component of the polycomb repressive complex 2 (PRC2). Known also as KMT6 EZH2 functions as a histone methyltransferase catalyzing the tri-methylation of histone H3 at lysine 27 (H3K27me3). This methylation activity is important for gene silencing. EZH2 has a molecular mass of approximately 85 kDa and is expressed in various tissues with higher expression often observed in embryonic stem cells and certain adult tissues such as prostate and breast tissue.
Biological function summary

EZH2 plays an important role in chromatin remodeling and transcriptional repression through its integration within the PRC2 complex which includes proteins such as SUZ12 and EED. This complex is involved in maintaining the transcriptional silencing of genes essential for development and differentiation. EZH2's activity regulates cell fate decisions and helps preserve stem cell pluripotency through repression of lineage-specific genes.

Pathways

EZH2 integrates into mechanisms often seen in the regulation of the Wnt and Hedgehog signaling pathways. These pathways are central to developmental processes and cell proliferation. In the Wnt pathway EZH2 interacts with proteins such as β-catenin impacting gene expression involved in cell growth. Similarly within the Hedgehog pathway EZH2 may influence gene regulation through its interaction with GLI transcription factors again affecting cellular proliferation and tissue patterning.

EZH2 has strong associations with cancer particularly in conditions like prostate cancer and lymphomas. Overexpression or mutations in EZH2 contribute to tumorigenesis by promoting aberrant silencing of tumor suppressor genes. In the context of lymphomas mutations in EZH2 can cooperate with alterations in associated proteins like BCL2 to drive oncogenesis. Furthermore therapeutic interventions targeting EZH2 are under investigation highlighting its relevance in disease progression and potential treatment.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Displays a preference for substrates with less methylation, loses activity when progressively more methyl groups are incorporated into H3K27, H3K27me0 > H3K27me1 > H3K27me2 (PubMed : 22323599, PubMed : 30923826). Compared to EZH1-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1, CDKN2A and retinoic acid target genes. EZH2 can also methylate non-histone proteins such as the transcription factor GATA4 and the nuclear receptor RORA. Regulates the circadian clock via histone methylation at the promoter of the circadian genes. Essential for the CRY1/2-mediated repression of the transcriptional activation of PER1/2 by the CLOCK-BMAL1 heterodimer; involved in the di and trimethylation of 'Lys-27' of histone H3 on PER1/2 promoters which is necessary for the CRY1/2 proteins to inhibit transcription.
See full target information EZH2

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com